Prediction of Human Drug Clearance from Two Species: A Comparison of Several Allometric Methods
被引:11
|
作者:
Goteti, Kosalaram
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca R&D Boston, Dept Drug Metab & Pharmacokinet, Waltham, MA 02451 USAAstraZeneca R&D Boston, Dept Drug Metab & Pharmacokinet, Waltham, MA 02451 USA
Goteti, Kosalaram
[1
]
Garner, C. Edwin
论文数: 0引用数: 0
h-index: 0
机构:
AstraZeneca R&D Boston, Dept Drug Metab & Pharmacokinet, Waltham, MA 02451 USAAstraZeneca R&D Boston, Dept Drug Metab & Pharmacokinet, Waltham, MA 02451 USA
Garner, C. Edwin
[1
]
Mahmood, Iftekhar
论文数: 0引用数: 0
h-index: 0
机构:
US FDA, OBRR, Ctr Biol Evaluat & Res, Rockville, MD USAAstraZeneca R&D Boston, Dept Drug Metab & Pharmacokinet, Waltham, MA 02451 USA
Mahmood, Iftekhar
[2
]
机构:
[1] AstraZeneca R&D Boston, Dept Drug Metab & Pharmacokinet, Waltham, MA 02451 USA
[2] US FDA, OBRR, Ctr Biol Evaluat & Res, Rockville, MD USA
The objective of the study was to assess the degree of accuracy in human drug clearance prediction from two species using four different allometric approaches: simple allometry (SA), multiexponential allometry (ME), rule of exponents (ROE), and fixed exponents (FE) as suggested by Tang et al. There were 45 compounds in this analysis and the two species used were either rat-dog or rat-monkey. In addition, >= 3 species scaling was also performed to evaluate the comparative accuracy in the prediction of human drug clearance between two or more than two-species scaling. The results of the study indicated that the two-species scaling with different methods provided different degrees of accuracy in the prediction of clearance. Prediction by a particular method was also species dependent. For example, a given drug with rat-dog scaling provided a reasonably accurate prediction of clearance whereas with rat-monkey scaling the prediction of clearance was highly erratic or vice versa. The results of the study indicated that the two-species scaling can be useful for prediction purposes but the prediction of clearance from >= 3 species was far more accurate than two-species scaling. (C) 2009 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 99:1601-1613, 2010
机构:
US FDA, Ctr Drug Evaluat & Res, Off Drug Evaluat 6, Clin Pharmacol & Toxicol Branch, Rockville, MD 20852 USAUS FDA, Ctr Drug Evaluat & Res, Off Drug Evaluat 6, Clin Pharmacol & Toxicol Branch, Rockville, MD 20852 USA
机构:
US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USAUS FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA
机构:
Merck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, GermanyMerck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, Germany
Yamagata, Tetsuo
Zanelli, Ugo
论文数: 0引用数: 0
h-index: 0
机构:
Merck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Darmstadt, GermanyMerck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, Germany
Zanelli, Ugo
Gallemann, Dieter
论文数: 0引用数: 0
h-index: 0
机构:
Merck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, GermanyMerck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, Germany
Gallemann, Dieter
Perrin, Dominique
论文数: 0引用数: 0
h-index: 0
机构:
Merck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Darmstadt, GermanyMerck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, Germany
Perrin, Dominique
Dolgos, Hugues
论文数: 0引用数: 0
h-index: 0
机构:
Merck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Darmstadt, GermanyMerck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, Germany
Dolgos, Hugues
Petersson, Carl
论文数: 0引用数: 0
h-index: 0
机构:
Merck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Darmstadt, GermanyMerck KGaA, Global Early Dev Quantitat Pharmacol & Drug Dispo, Grafing, Germany